Pharmacokinetics and Biodistribution Studies of Doxorubicin Loaded Poly(butyl Cyanoacrylate) Nanoparticles Synthesized by Two Different Techniques

Abstract

The aim of the study is to determine and compare the pharmacokinetics and tissue distribution of Doxorubicin (Dox) delivered as solution or through nanoparticles after intravenous (i.v.) and intraperitoneal (i.p.) injection. Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles were synthesized by dispersion polymerization (DP) and emulsion polymerization (EP) techniques. The drug loaded DP and EP nanoparticles were administered by i.v. or i.p. routes and the respective pharmacokinetics and tissue distribution were determined. Both types of nanoparticles significantly enhanced the elimination half-life (T 1/2 ), mean residence time (MRT) AUC [0][1][2][3][4][5][6][7][8] , AUC 0-∞ and AUMC 0-8 of Dox in blood after i.v. injection. Dox delivered through DP nanoparticles rapidly disappeared from blood and distributed to the organs of reticuloendothelial system (RES). But, the clearance of Dox delivered through EP nanoparticles from blood was slower than this of the DP nanoparticles and Dox solution. After i.p. injection, the Dox loaded into DP nanoparticles quickly appeared in blood and undergone rapid distribution to the organs of RES, while the Dox loaded into EP nanoparticles absorbed slowly into blood and remained in the circulation for longer time. The absorption into blood of Dox delivered through DP and EP nanoparticles after i.p. injection was relatively rapid and higher than Dox solution. The T 1/2 , MRT, AUC [0][1][2][3][4][5][6][7][8] , AUC 0-∞ and AUMC 0-8 of Dox in blood were significantly higher and the clearance (Cl) was lower than for the Dox solution after i.p. injection. The tissue concentrations of Dox delivered through nanoparticles after i.p. injection were significantly lower than after i.v. injection. The bioavailability (F) of Dox was greatly enhanced by DP (∼1.9 fold) and EP nanoparticles (∼2.12 fold) compared to Dox solution after i.p. injection. EP nanoparticles significantly enhanced the bioavailability, MRT, T 1/2 , AUC 0-8 , AUC 0-∞ and AUMC 0-8 of Dox than DP nanoparticles. This signifies the advantage of EP nanoparticles in increasing the elimination half-life of Dox both after i.v. and i.p. injection and enhanced bioavailability after i.p. injection, which is expected to improve the therapeutic efficacy of Dox and reduce the Dox-associated systemic toxicity. Importantly, both DP and EP nanoparticles greatly reduced the distribution of Dox to heart both after i.v. and i.p. injection, suggesting their potential in reducing Dox-associated cardiotoxicity.

Multifunctional Nanoparticles in Cancer: in vitro Characterization, in vivo Distribution

“…The bioavailability of IR820 is increased by using NPs, as the elimination half-life of IR820-PGMD NPs and DOX-IR820-PGMD NPs is 1.4 times and 1.3 times the free IR820 elimination half-life, respectively. All the calculated physiology parameters indicated prolonged blood circulation with nanoformulation and the cumulative exposure to body organs is also enhanced, similar results were also reported in other studies (127,128).…”

Biodistribution and anti-tumor activities of the 131I-labeled rituximab in nude mice bearing human Burkitt’s lymphoma

“…One efficient approach used to circumvent this problem is intratumoral injection of the labeled monoclonal antibody [7][8][9] . In this experiment, we studied the distribution and antitumor activity of 131 I labeled Rituximab injected intratumorally or intraperitoneally in vivo in nude mice bearing Raji human Burkitt' s lymphoma xenografts, which provided some experimental evidence for the clinical applications of radioimmunotherapy.…”

Novel anionic polymer as a carrier for CNS delivery of anti-Alzheimer drug

“…The formulations were given intravenously at a dose level equivalent to 0.9 mg/kg body weight, after resuspending in 0.3% CMC (carboxy methyl cellulose). After 1 h the rats were killed by decapitation after which the brain, lungs and kidneys were quickly removed, weighed and homogenized separately in PBS, pH 7.4, to give a 20% w/v concentration (Reddy & Murthy, 2004). The samples were centrifuged and the supernatant was stored at -20 C until analysis.…”